Immunological changes after COVID-19 vaccination in an HIV-positive patient

Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Changlin, Song, Xiaojing, Li, Xiaoxia, Lu, Lianfeng, Li, Taisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373846/
https://www.ncbi.nlm.nih.gov/pubmed/34419582
http://dx.doi.org/10.1016/j.ijid.2021.08.039
_version_ 1783739989672067072
author Gong, Changlin
Song, Xiaojing
Li, Xiaoxia
Lu, Lianfeng
Li, Taisheng
author_facet Gong, Changlin
Song, Xiaojing
Li, Xiaoxia
Lu, Lianfeng
Li, Taisheng
author_sort Gong, Changlin
collection PubMed
description Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy.
format Online
Article
Text
id pubmed-8373846
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-83738462021-08-19 Immunological changes after COVID-19 vaccination in an HIV-positive patient Gong, Changlin Song, Xiaojing Li, Xiaoxia Lu, Lianfeng Li, Taisheng Int J Infect Dis Article Vaccination is an essential measure to stop the coronavirus disease 2019 (COVID-19) pandemic. We report a case of viral activation and CD4+ T cell loss in a treatment-naïve HIV-positive patient after receiving inactivated COVID-19 vaccine (Sinopharm). The vaccine should probably be given only to people living with HIV receiving antiretroviral therapy. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-04 2021-08-19 /pmc/articles/PMC8373846/ /pubmed/34419582 http://dx.doi.org/10.1016/j.ijid.2021.08.039 Text en © 2021 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gong, Changlin
Song, Xiaojing
Li, Xiaoxia
Lu, Lianfeng
Li, Taisheng
Immunological changes after COVID-19 vaccination in an HIV-positive patient
title Immunological changes after COVID-19 vaccination in an HIV-positive patient
title_full Immunological changes after COVID-19 vaccination in an HIV-positive patient
title_fullStr Immunological changes after COVID-19 vaccination in an HIV-positive patient
title_full_unstemmed Immunological changes after COVID-19 vaccination in an HIV-positive patient
title_short Immunological changes after COVID-19 vaccination in an HIV-positive patient
title_sort immunological changes after covid-19 vaccination in an hiv-positive patient
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373846/
https://www.ncbi.nlm.nih.gov/pubmed/34419582
http://dx.doi.org/10.1016/j.ijid.2021.08.039
work_keys_str_mv AT gongchanglin immunologicalchangesaftercovid19vaccinationinanhivpositivepatient
AT songxiaojing immunologicalchangesaftercovid19vaccinationinanhivpositivepatient
AT lixiaoxia immunologicalchangesaftercovid19vaccinationinanhivpositivepatient
AT lulianfeng immunologicalchangesaftercovid19vaccinationinanhivpositivepatient
AT litaisheng immunologicalchangesaftercovid19vaccinationinanhivpositivepatient

Ejemplares similares